Michelle Smith is Novotech’s Associate Project Director, bringing extensive experience across all phases of clinical trials, with broad therapeutic area expertise and a strong focus on global full-service project delivery.
Based in Australia, Michelle has been with Novotech for more than 14 years, holding roles across project oversight, portfolio management, integration operations, project management, and clinical research. Her experience spans early phase, oncology, vaccines, stroke, HBV, dermatology, renal disease, arthritis, Alzheimer’s disease, and gout studies across Australia, New Zealand, Asia-Pacific, the United States, and South Africa. Michelle holds a PhD in Medicine from the University of Sydney.